Health Tech Companies Secure $427 Million in December Funding

Health technology firms announced significant funding rounds in December 2023, raising a combined total of approximately $427 million. These investments are aimed at scaling operations and enhancing services in a sector increasingly focused on innovative healthcare solutions.

Curative Secures $150 Million

Based in Austin, Texas, Curative has successfully raised $150 million in Series B funding. The company offers an employer-based health plan that eliminates out-of-pocket costs, including co-pays, deductibles, and coinsurance, requiring members to complete only an annual preventative health visit. The funding round, led by Chris Anderson‘s Upside Vision Fund, saw participation from notable investors such as Justin Mateen, founder of JAM Fund, and Mike Novogratz of Galaxy Digital. The investment will facilitate Curative’s national expansion, enabling more employers to access their zero-cost health plans.

Angle Health Raises $134 Million

In another major announcement, Angle Health raised $134 million in Series B funding. The San Francisco-based company provides digital healthcare benefits for employers, utilizing an AI-powered app for care navigation and offering customizable health plans that include telemedicine and behavioral health services. The funding round attracted various investors, including Portage, Blumberg Capital, and Y Combinator, and comprised a mix of debt and equity. Overall, Angle Health has now secured around $200 million in funding to date, supporting its services for over 3,000 employers across 44 states.

Paradigm Health and Artera Join the Funding Wave

Paradigm Health garnered $78 million in Series B funding for its AI-driven platform that aims to enhance patient access to clinical trials. The investment, led by ARCH Venture Partners and supported by firms such as DFJ Growth and the American Cancer Society’s BrightEdge Fund, will enable Paradigm to expand its services, responding to the increased demand from biopharmaceutical companies for efficient trial processes.

Meanwhile, Artera, based in Santa Barbara, California, raised $65 million to further develop its AI solutions that streamline communication between healthcare providers and patients. The funding was backed by investors including Lead Edge Capital and Jackson Square Ventures, facilitating Artera’s growth and the integration of advanced AI technologies in healthcare communication.

These funding announcements reflect a robust interest in health technology innovation, as companies seek to improve patient care and operational efficiencies in an evolving healthcare landscape.